Reference
WHO. http://www.who.int/gho/hiv/en/.
Yedavalli VRK and Jeang K-T. Methylation: A
regulator of hiv-1 replication? Retrovirology (2007)
4: 9.
Tan J, Su M, Zeng Y and Wang C. Design, synthesis
and activity evaluation of novel peptide fusion
inhibitors targeting hiv-1 gp41. Bioorg. Med. Chem.
(2016) 24: 201-6.
Kinch MS and Patridge E. An analysis of fda-approved
drugs for infectious disease: HIV/AIDS drugs. Drug
Discov. Today (2014) 19: 1510-3.
United nationsfact sheet november 2016. Available
from www.UNAIDS.Org/en/dataanalysis/.
Hajimahdi Z, Ranjbar A, Abolfazl Suratgar A and
Zarghi A. QSAR study on anti-hiv-1 activity of 4-oxo1,4-dihydroquinoline and 4-oxo-4H-pyrido[1,2-a]
pyrimidine derivatives using SW-MLR, artificial
neural network and filtering methods. Iran. J. Pharm.
Res. (2015) 14: 69-75.
Hajimahdi Z, Safizadeh F and Zarghi A. QSAR analysis
for some 1, 2-benzisothiazol-3-one derivatives as
caspase-3 inhibitors by stepwise MLR method. Iran.
J. Pharm. Res. (2016) 15: 439-48.
Ojha Lokendra K, Rachana S and Rani BM. Modern
drug design with advancement in QSAR: A review.
Int. J. Res. Biosci. (2013) 2: 1-12.
Hajimahdi Z, Zabihollahi R, Aghasadeghi MR and
Zarghi A. Design, synthesis and docking studies of
new 4-hydroxyquinoline-3-carbohydrazide derivatives
as anti-HIV-1 agents. Drug Res. (2013) 63: 192-7.
Hajimahdi Z, Zarghi A, Zabihollahi R and Aghasadeghi
MR. Synthesis, biological evaluation, and molecular
modeling studies of new 1,3,4-oxadiazole- and
1,3,4-thiadiazole-substituted 4-oxo-4H-pyrido[1,2-a]
pyrimidines as anti-HIV-1 agents. Med. Chem. Res.
(2013) 22: 2467–75.
Hajimahdi Z, Zabihollahi R, Aghasadeghi MR, Ashtiani
SH and Zarghi A. Novel quinolone-3-carboxylic acid
derivatives as anti-HIV-1 agents: Design, synthesis,
and biological activities. Med. Chem. Res. (2016) 25:
1861-76.
Hajimahdi Z and Zarghi A. Progress in HIV-1 integrase
inhibitors: A review of their chemical structure
diversity. Iran. J. Pharm. Res. (2016) 15: 595-628.
Livani ZA, Safakish M, Hajimahdi Z, Soleymani
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
Docking and QSAR Study of anti-HIV compounds
1263
S, Zabihollahi R, Aghasadeghi MR, Alipour E and
Zarghi A. Design, synthesis, molecular modeling, in
silico ADME studies and anti-HIV-1 assay of new
diazocoumarin derivatives. Iran. J. Pharm. Res.
(2018) 17(Special Issue 2): 65-77.
Safakish M, Hajimahdi Z, Zabihollahi R, Aghasadeghi
MR, Vahabpour R and Zarghi A. Design, synthesis,
and docking studies of new 2-benzoxazolinone
derivatives as anti-HIV-1 agent. Med. Chem. Res.
(2017) 26: 2718–26.
Yap CW. PaDel‐descriptor: An open source software
to calculate molecular descriptors and fingerprints. J.
Comput. Chem. (2011) 32: 1466-74.
Marleau G, Hebert A and Roy R. A user guide for
Dragon release 3.06 o (2016/02/01). (2016)
Todeschini R, Consonni V and Pavana M, Milano
chemometrics and QSAR group. (2008)
Guyon I and Elisseeff A. An introduction to variable
and feature selection. J. Mach. Learn. Res. (2003) 3:
1157-82.
Nathans LL, Oswald FL and Nimon K. Interpreting
multiple linear regression: A guidebook of variable
importance. Practical Assessment, Research &
Evaluation (2012) 17: 1-19.
Akbari S, Zebardast T, Zarghi A and Hajimahdi Z.
QSAR modeling of COX -2 inhibitory activity of
some dihydropyridine and hydroquinoline derivatives
using multiple linear regression (MLR) method. Iran.
J. Pharm. Res. (2017) 16: 525-32.
Trott O and Olson AJ. Autodock Vina: Improving the
speed and accuracy of docking with a new scoring
function, efficient optimization, and multithreading. J.
Comput. Chem. . (2010) 31: 455-61.
Morris GM, Goodsell DS, Halliday RS, Huey R,
Hart WE, Belew RK and Olson AJ. Automated
docking using a Lamarckian genetic algorithm and
and empirical binding free energy function. J. Comput.
Chem. (1998) 19: 1639-62.
Mukaka MM. Statistics corner: A guide to appropriate
use of correlation coefficient in medical research.
Malawi Med. J. (2012) 24: 69-71.
Wu W, Zhang C, Lin W, Chen Q, Guo X, Qian Y and
Zhang L. Quantitative structure-property relationship
(QSAR) modeling of drug-loaded polymeric micelles
via genetic function approximation. PLOS ONE (2015)
10: e0119575.
Gramatica P. Principles of QSAR models validation:
Internal and external. QSAR Comb. Sci. . (2007) 26:
694-701.
Todeschini R and Consonni V, Handbook of Molecular
Descriptors. Vol. 11, John Wiley & Sons. (2008)
Todeschini R and Consonni V, Methods and principles
in medicinal chemistry: Handbook of molecular
descriptors. Volume 11, editor: Mannhold r., kubinyi
h. And timmerman h. Wiley-VCH: Weinheim. (2000)
Consonni V, Todeschini R, Pavan M and Gramatica P.
Structure/response correlations and similarity/diversity
analysis by getaway descriptors. 2. Application of
the novel 3D molecular descriptors to QSAR/QSPR
studies. J. Chem. Inf. Comput. Sci. (2002) 42: 693-705.
Hall LH and Kier LB. Electrotopological state indices
for atom types: A novel combination of electronic,
topological, and valence state information. J. Chem.
Inf. Comput. Sci. (1995) 35: 1039-45.
Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y, Duan
J and Ling Y. A novel chemometric method for the
prediction of human oral bioavailability. Int. J. Mol.
Sci. (2012) 13: 6964-82.
Uesawa Y, Hishinuma S and Shoji M. Molecular
determinants responsible for sedative and non-sedative
properties of histamine H1–receptor antagonists. J.
Pharmacol. Sci. . (2014) 124: 160-8.
Neugebauer A, Hartmann RW and Klein CD.
Prediction of protein− protein interaction inhibitors by
chemoinformatics and machine learning methods. J.
Med. Chem. (2007) 50: 4665-8.
Gasteiger J, Sadowski J, Schuur J, Selzer P, Steinhauer
L and Steinhauer V. Chemical information in 3D
space. J. Chem. Inf. Comput. Sci. (1996) 36: 1030-7.
)